Cardiac Monitoring Market is expected to reach $23.3 Billion by 2017

Cardiac monitoring devices have witnessed a remarkable importance for the past decade. These implantable devices are used to treat cardiac arrhythmias (or abnormal heart rhythms), sudden cardiac arrest, and heart failure. These devices are the forefront of Cardiac Rhythm Management therapy to treat a number of cardiac conditions. The global cardiac monitoring and cardiac rhythm management market is expected to grow at a healthy pace in the next five years due to many factors like the increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoring.

                                              Source: http://images.publicradio.org/

According to a new market research report by MarketsandMarkets, the cardiac monitoring market is expected to reach $23.3 billion by 2017. The cardiac monitoring market includes ECG, Holter monitors, implantable loop recorder (ILR), event monitors, and cardiac output monitors. ECG is the largest segment, while ILR is the fastest growing segment of the conventional cardiac monitoring market. The cardiac rhythm management market is further segmented into defibrillators, pacemakers, and cardiac resynchronization therapy devices. The report provides the detailed analysis of the CRM market and forecasts up to 2017.

                                           Source: http://admittancetechnologies.com/

North America shares the largest part of the cardiac monitoring and cardiac rhythm management market, followed by Europe and Asia. The key players in the cardiac monitoring and cardiac rhythm management market are Boston Scientific (U.S.),Cardiac Science Corporation (U.S.), Medtronic (U.S.), Mortara Instruments (U.S.), GE Healthcare (U.K.), LifeWatch (Switzerland), Schiller (Switzerland), Spacelabs Healthcare (U.S.), St. Jude Medical (U.S.), Philips Healthcare (The Netherlands), CardioNet (U.S.), Welch Allyn (U.S.), and Zoll Medical Corporation (U.S.).

The report can be referred here:
http://www.prweb.com/releases/cardiac-monitoring/technologies-market/prweb11657777.htm